Literature DB >> 25321077

A model for predicting gastrostomy tube placement in patients undergoing surgery for upper aerodigestive tract lesions.

Ashley C Mays1, Farah Moustafa2, Mitch Worley2, Joshua D Waltonen1, Ralph D'Agostino3.   

Abstract

IMPORTANCE: Identifying high-risk patients in the preoperative period can allow physicians to optimize nutritional status early for better outcomes after head and neck cancer resections.
OBJECTIVE: To develop a model to predict preoperatively the need for gastrostomy tube (G-tube) placement in patients undergoing surgery of the upper aerodigestive tract. DESIGN, SETTING, AND PARTICIPANTS: This retrospective medical record review included all adult patients diagnosed with head and neck cancers who underwent tumor resection from 2007 through 2012 at Wake Forest Baptist Health, a level 1 tertiary care center. Records were screened for patient demographics, tumor characteristics, surgical treatment type, and postoperative placement of G-tube. A total of 743 patients underwent resection of head and neck tumors. Of these, 203 were excluded for prior G-tube placement, prior head and neck resection, G-tube placement for chemoradiotherapy, and resection for solely nodal disease, leaving 540 patients for analysis. MAIN OUTCOMES AND MEASURES: Placement of postoperative G-tube.
RESULTS: Of the 540 included patients, 23% required G-tube placement. The following variables were significant and independent predictors of G-tube placement: preoperative irradiation (odds ratio [OR], 4.1; 95% CI, 2.4-6.9; P < .001), supracricoid laryngectomy (OR, 26.0; 95% CI, 4.9-142.9; P < .001), tracheostomy tube placement (OR, 2.6; 95% CI, 1.5-4.4; P < .001), clinical node stage N0 vs N2 (OR, 2.4; 95% CI, 1.4-4.2; P = .01), clinical node stage N1 vs N2 (OR, 1.6; 95% CI, 0.8-3.3; P = .01), preoperative weight loss (OR, 2.0; 95% CI, 1.2-3.2; P = .004), dysphagia (OR, 2.0; 95% CI, 1.2-3.2; P = .005), reconstruction type (OR, 1.9; 95% CI, 1.1-2.9; P = .02), and tumor stage (OR, 1.8; 95% CI, 1.1-2.9; P = .03). A predictive model was developed based on these variables. In the validation analysis, we found that the average predicted score for patients who received G-tubes was statistically different than the score for the patients who did not receive G-tubes (P = .01). CONCLUSIONS AND RELEVANCE: We present a validated and comprehensive model for preoperatively predicting the need for G-tube placement in patients undergoing surgery of the upper aerodigestive tract. Early enteral access in high-risk patients may prevent complications in postoperative healing and improve overall outcomes, including quality of life.

Entities:  

Mesh:

Year:  2014        PMID: 25321077      PMCID: PMC4321944          DOI: 10.1001/jamaoto.2014.2360

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  16 in total

1.  Guideline for prophylactic feeding tube insertion in patients undergoing resection of head and neck cancers.

Authors:  David R Jack; Fiona R Dawson; Justice E Reilly; Taimur Shoaib
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-12-01       Impact factor: 2.740

2.  The impact of nutritional status on the prognoses of patients with advanced head and neck cancer.

Authors:  P A van Leeuwen; D J Kuik; W M Klop; H P Sauerwein; G B Snow; J J Quak
Journal:  Cancer       Date:  1999-08-01       Impact factor: 6.860

Review 3.  Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.

Authors:  Brenda Nugent; Sian Lewis; Joe M O'Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 4.  Recurrent metastatic spread to a percutaneous gastrostomy site in a patient with squamous cell carcinoma of the tongue: a case report and review of the literature.

Authors:  Avinoam Nevler; Iris Gluck; Nora Balint-Lahat; Danny Rosin
Journal:  J Oral Maxillofac Surg       Date:  2013-11-16       Impact factor: 1.895

5.  Gastrostomy tubes in patients with advanced head and neck cancer.

Authors:  Khwaja Asif Ahmed; Sandeep Samant; Francisco Vieira
Journal:  Laryngoscope       Date:  2005-01       Impact factor: 3.325

6.  Predicting the need for prolonged enteral supplementation in the patient with head and neck cancer.

Authors:  R L Gardine; W A Kokal; J D Beatty; D U Riihimaki; L D Wagman; J J Terz
Journal:  Am J Surg       Date:  1988-07       Impact factor: 2.565

7.  Effect of body mass index on chemoradiation outcomes in head and neck cancer.

Authors:  Theodore R McRackan; John M Watkins; Amy E Herrin; Elizabeth M Garrett-Mayer; Anand K Sharma; Terry A Day; M Boyd Gillespie
Journal:  Laryngoscope       Date:  2008-07       Impact factor: 3.325

8.  Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study.

Authors:  R G J Wiggenraad; L Flierman; A Goossens; R Brand; H P Verschuur; G A Croll; L E C Moser; R Vriesendorp
Journal:  Clin Otolaryngol       Date:  2007-10       Impact factor: 2.597

9.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review.

Authors:  Stephen Mangar; Nicholas Slevin; Kathleen Mais; Andrew Sykes
Journal:  Radiother Oncol       Date:  2006-02-07       Impact factor: 6.280

View more
  7 in total

1.  Potential for health care cost savings with preoperative gastrostomy tube placement in the head and neck cancer population.

Authors:  Ashley C Mays; Harrison G Bartels; Paul R Wistermayer; Matt L Rohlfing; Christopher M Gentile; Ralph D'Agostino; Joshua D Waltonen
Journal:  Head Neck       Date:  2017-11-13       Impact factor: 3.147

2.  Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck.

Authors:  Mitchell L Worley; Evan M Graboyes; Julie Blair; Suhael Momin; Kent E Armeson; Terry A Day; Andrew T Huang
Journal:  Otolaryngol Head Neck Surg       Date:  2018-03-20       Impact factor: 3.497

3.  The association between gastrostomy tube placement, poor post-operative outcomes, and hospital re-admissions in head and neck cancer patients.

Authors:  Ashley C Mays; Mitchell Worley; Feras Ackall; Ralph D'Agostino; Joshua D Waltonen
Journal:  Surg Oncol       Date:  2015-08-12       Impact factor: 3.279

Review 4.  Position paper of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery and the German Society of Phoniatrics and Pediatric Audiology - Current state of clinical and endoscopic diagnostics, evaluation, and therapy of swallowing disorders in children.

Authors:  Christoph Arens; Ingo F Herrmann; Saskia Rohrbach; Cornelia Schwemmle; Tadeus Nawka
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

5.  The prognostic value of preoperative prognostic nutritional index in patients with hypopharyngeal squamous cell carcinoma: a retrospective study.

Authors:  Lu-Lu Ye; Ronald Wihal Oei; Fang-Fang Kong; Cheng-Run Du; Rui-Ping Zhai; Qing-Hai Ji; Chao-Su Hu; Hong-Mei Ying
Journal:  J Transl Med       Date:  2018-01-24       Impact factor: 5.531

Review 6.  Nutritional Issues in Head and Neck Cancer Patients.

Authors:  Federico Bozzetti; Paolo Cotogni
Journal:  Healthcare (Basel)       Date:  2020-04-17

7.  A European survey on the practice of nutritional interventions in head-neck cancer patients undergoing curative treatment with radio(chemo)therapy.

Authors:  Federico Bozzetti; Cristina Gurizzan; Simon Lal; Andre' Van Gossum; Geert Wanten; Wojciech Golusinski; Sefik Hosal; Paolo Bossi
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-19       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.